We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXPE:NASDAQExpedia Group, Inc. Analysis

Data as of 2026-03-10 - not real-time

$232.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Expedia shares surged 13.7% to $251.54 on March 5, driven by a 20% dividend increase and investor enthusiasm to capture the upcoming payout. The rally lifted the stock well above its 20‑day SMA of $218.6, while the MACD histogram turned positive (+6.0) indicating short‑term bullish momentum. However, the RSI sits near 50 and the trend direction is neutral, suggesting the price may consolidate near the current resistance around $252. Volume has been decreasing, which could temper further upside in the immediate term.
On the fundamentals side, EXPE posted 11% year‑over‑year revenue growth to $14.73 billion and expanded operating margin to 15.5%, reflecting a resilient travel recovery. Cash generation remains strong with $5.73 billion in cash and free cash flow of $2.93 billion, supporting a modest 16% payout ratio. The DCF fair value of roughly $530 places the current price of $232 well below intrinsic value, implying an upside of about 20% and a forward PE of 10×. The company’s high ROE of 48% and low dividend payout further underscore its capacity to sustain earnings growth.
Given the valuation gap and solid balance sheet, the stock is positioned as an undervalued growth play in the consumer‑cyclical travel sector. The recent AI‑related market rally removed a potential competitive threat, adding a catalyst for continued market share gains. Nonetheless, the sector’s sensitivity to economic cycles and a beta of 1.55 warrant caution on the downside. Overall, a balanced approach that leans toward buying on dips aligns with the medium‑ and long‑term upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent dividend hike boosting short‑term demand
  • Positive MACD histogram indicating momentum
  • Decreasing volume suggesting limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation shows ~20% upside
  • Strong revenue and margin expansion
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term travel demand recovery
  • Robust cash flow and high ROE
  • AI pivot reducing competitive pressure

Key Metrics & Analysis

Financial Health

Revenue Growth11.40%
Profit Margin8.78%
P/E Ratio23.7
ROE48.67%
ROA5.77%
Debt/Equity254.69
P/B Ratio22.2
Op. Cash Flow$3.9B
Free Cash Flow$2.9B

Technical Analysis

TrendNeutral
RSI50.4
Support$185.34
Resistance$252.23
MA 20$218.59
MA 50$252.54
MA 200$222.56
MACDBullish
VolumeDecreasing
Fear & Greed Index80.21

Valuation

Fair Value$529.88
Target Price$280.85
Upside/Downside20.83%
GradeUndervalued
TypeGrowth
Dividend Yield0.70%

Risk Assessment

Beta1.55
Volatility81.28%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.